Cargando…

Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

In rheumatoid arthritis (RA), the identification of biomarkers to adjust treatment intensity and to correctly diagnose the disease in early stages still constitutes a challenge and, as such, novel biomarkers are needed. We proposed that autoantibodies (aAbs) against CD26 (DPP4) might have both etiol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordero, Oscar J., Viéitez, Irene, Altabás, Irene, Nuño-Nuño, Laura, Villalba, Alejandro, Novella-Navarro, Marta, Peiteado, Diana, Miranda-Carús, María-Eugenia, Balsa, Alejandro, Varela-Calviño, Rubén, Gomez-Tourino, Iria, Pego-Reigosa, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933303/ https://www.ncbi.nlm.nih.gov/pubmed/35304639 http://dx.doi.org/10.1007/s00005-022-00649-6

Ejemplares similares

Distinctive CD26 Expression on CD4 T-Cell Subsets
por: Cordero, Oscar J., et al.
Publicado: (2021)

Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
por: Novella -Navarro, Marta, et al.
Publicado: (2023)

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
por: Benavent, Diego, et al.
Publicado: (2022)

Correction: CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis
por: Cordero, Oscar J., et al.
Publicado: (2015)

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2020)

Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases
por: Nuño, Laura, et al.
Publicado: (2020)

Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
por: Rafael-Vidal, Carlos, et al.
Publicado: (2020)

Decreased Frequencies of Circulating Follicular Helper T Cell Counterparts and Plasmablasts in Ankylosing Spondylitis Patients Naïve for TNF Blockers
por: Bautista-Caro, María-Belén, et al.
Publicado: (2014)

Increased frequency of circulating CD19+CD24(hi)CD38(hi) B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents
por: Bautista-Caro, María-Belén, et al.
Publicado: (2017)

Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
por: Rafael-Vidal, Carlos, et al.
Publicado: (2021)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Regueiro, Cristina, et al.
Publicado: (2017)

Validity of the EULAR recommendations on the use of ultrasound in the diagnosis of giant cell arteritis
por: Fernández-Fernández, Elisa, et al.
Publicado: (2022)

CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis
por: Cordero, Oscar J., et al.
Publicado: (2015)

Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis
por: Arroyo-Villa, Irene, et al.
Publicado: (2014)

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia
por: Novella-Navarro, Marta, et al.
Publicado: (2021)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics
por: Regueiro, Cristina, et al.
Publicado: (2019)

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
por: Plasencia, Chamaida, et al.
Publicado: (2013)

Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies
por: Rodriguez-Martínez, Lorena, et al.
Publicado: (2020)

Naturally presented HLA class I–restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes
por: Calviño-Sampedro, Cristina, et al.
Publicado: (2019)

Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
por: Plasencia-Rodríguez, Chamaida, et al.
Publicado: (2023)

Frequency of Th17 CD4+ T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP Seropositivity
por: Arroyo-Villa, Irene, et al.
Publicado: (2012)

Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
por: Benavent, Diego, et al.
Publicado: (2020)

Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients
por: Jurado, Teresa, et al.
Publicado: (2017)

CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context
por: De Chiara, Loretta, et al.
Publicado: (2020)

Oral hygiene might prevent cancer
por: Cordero, Oscar J., et al.
Publicado: (2018)

Healthcare-related impact of gout in hospitalized patients in Spain
por: Benavent, Diego, et al.
Publicado: (2021)

The TT Genotype of the STAT4 rs7574865 Polymorphism Is Associated with High Disease Activity and Disability in Patients with Early Arthritis
por: Lamana, Amalia, et al.
Publicado: (2012)

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study
por: Bogas, Patricia, et al.
Publicado: (2021)

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
por: Regueiro, Cristina, et al.
Publicado: (2021)

Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort
por: Altabás-González, Irene, et al.
Publicado: (2022)

Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions
por: Plasencia, Chamaida, et al.
Publicado: (2015)

Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment
por: Bartels, Frederik, et al.
Publicado: (2018)

Anti-rods and rings autoantibodies can occur in the hepatitis c-naïve population
por: SHAIKH, Y., et al.
Publicado: (2013)

Comment on: Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Reply
por: Pego-Reigosa, José M, et al.
Publicado: (2021)

T cell receptor β-chains display abnormal shortening and repertoire sharing in type 1 diabetes
por: Gomez-Tourino, Iria, et al.
Publicado: (2017)

IL-15 Expression on RA Synovial Fibroblasts Promotes B Cell Survival
por: Benito-Miguel, Marta, et al.
Publicado: (2012)

Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor
por: Balsa, Alejandro, et al.
Publicado: (2010)

Clinical and serological study of 26 patients with anti-SL (Ki) autoantibodies
por: Cavazzana, I, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ib0e2nhboils00cp7n2o7nhjtb